Richard Valeix

Richard Valeix

Corporate Officer/Principal presso TELIX PHARMACEUTICALS LIMITED

49 anni
Health Technology
Consumer Services
Distribution Services

Provenienza dei contatti di primo grado di Richard Valeix

EntitàTipo di entitàSettore Industriale
Subsidiary Medical Specialties 32
Public Company Biotechnology 29
3
Subsidiary Wholesale Distributors 3
2
Subsidiary Biotechnology 2

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a Richard Valeix tramite i suoi contatti personali

SocietàSettorePersone collegatePosizione principale
ELI LILLY AND COMPANY Pharmaceuticals: Major

Tiffany Olson

Kapil Dhingra

Corporate Officer/Principal

Corporate Officer/Principal

NPS PHARMACEUTICALS, INC. Pharmaceuticals: Major

Francois Nader

Christine Cvijic

Chief Executive Officer

General Counsel

ABEONA THERAPEUTICS INC. Pharmaceuticals: Major

Stefano Buono

Edward Sturchio

Director/Board Member

General Counsel

PROGENICS PHARMACEUTICALS, INC. Pharmaceuticals: Major

Gérard Ber

Heinz Christoph Mäusli

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Susanne Antonie Schaffert

Chief Executive Officer

DOMINION MINERALS LIMITED Construction Materials

Christian Behrenbruch

Melanie Farris

Director/Board Member

Director/Board Member

Medical Specialties

Gérard Ber

Heinz Christoph Mäusli

Director/Board Member

Director/Board Member

Melbourne Business School College/University

David Cade

Jonathan Barlow

Masters Business Admin

Undergraduate Degree

NOVARTIS AG Pharmaceuticals: Major

Susanne Antonie Schaffert

Marie-France Tschudin

Sidonie Roswitha Golombowski-Daffner

Lena Moran-Adams

Investor Relations Contact

Corporate Officer/Principal

Corporate Officer/Principal

General Counsel

SIRTEX MEDICAL LIMITED Miscellaneous Commercial Services

Darren Smith

David Cade

Kevin Richardson

Craig Ulrick

Director of Finance/CFO

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

College/University

Christian Behrenbruch

Mark Nelson

Gabriel Liberatore

Graduate Degree

Doctorate Degree

Doctorate Degree

University of Cambridge College/University

Mark Nelson

Michael Wheatcroft

Graduate Degree

Doctorate Degree

College/University

Tracey Brown

David Cade

Genevieve Ryan

Doctorate Degree

Doctorate Degree

Graduate Degree

PHILOGEN S.P.A. Pharmaceuticals: Major

Leopoldo Giampaolo Zambeletti

Eugenio Aringhieri

Director/Board Member

Director/Board Member

Rutgers State University of New Jersey College/University

Christine Cvijic

Niva Almaula

Undergraduate Degree

Doctorate Degree

Information Technology Services

Stefano Buono

Corporate Officer/Principal

Georgetown University College/University

Marie-France Tschudin

Jessica Toepfer

Undergraduate Degree

Undergraduate Degree

ENDOCYTE, INC. Pharmaceuticals: Major

Susanne Antonie Schaffert

Director/Board Member

ONCOSIL MEDICAL LIMITED Medical Specialties

Douglas Cubbin

Gabriel Liberatore

Chairman

Director/Board Member

Friedrich-Alexander University of Erlangen-Nuremberg College/University

Susanne Antonie Schaffert

Doctorate Degree

University of Bocconi College/University

Claudio Costamagna

Leopoldo Giampaolo Zambeletti

Undergraduate Degree

Undergraduate Degree

Université Paris 1 Panthéon-Sorbonne College/University

Christian Merle

Muriel de Szilbereky

Graduate Degree

Graduate Degree

RMIT University College/University

Tracey Brown

Jyoti Arora

Graduate Degree

Doctorate Degree

Sciences Po College/University

Christian Merle

Muriel de Szilbereky

Undergraduate Degree

Undergraduate Degree

École des Hautes Études Commerciales de Paris College/University

Christian Behrenbruch

Jessica Toepfer

Masters Business Admin

Graduate Degree

Miscellaneous Commercial Services

Darren Smith

David Cade

Melanie Farris

Douglas Cubbin

Gabriel Liberatore

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Raffaele Petrone

Chief Executive Officer

Cell Therapies Pty Ltd.

Christian Behrenbruch

Jyoti Arora

Chairman

Corporate Officer/Principal

Pharmaceuticals: Major

Gérard Ber

Sales & Marketing

Medical/Nursing Services

Tiffany Olson

Kapil Dhingra

Director/Board Member

Chairman

Medical Distributors

Raffaele Petrone

Chief Executive Officer

Medical Distributors

Raffaele Petrone

Corporate Officer/Principal

LANTHEUS HOLDINGS, INC. Medical Specialties

Gérard Ber

Heinz Christoph Mäusli

Director/Board Member

Director/Board Member

European Association of Euro-Pharmaceutical Cos.

Raffaele Petrone

Chairman

Medical Specialties

Gérard Ber

Heinz Christoph Mäusli

Director/Board Member

Director/Board Member

RUBIUS THERAPEUTICS Biotechnology

Susanne Antonie Schaffert

Director/Board Member

RELIEF THERAPEUTICS HOLDING SA Pharmaceuticals: Major

Raffaele Petrone

Chief Executive Officer

Y-MABS THERAPEUTICS, INC. Pharmaceuticals: Major

Gérard Ber

Director/Board Member

Medical Specialties

Gérard Ber

Director/Board Member

Electronic Components

Susanne Antonie Schaffert

Sidonie Roswitha Golombowski-Daffner

Director/Board Member

Chief Executive Officer

Real Estate Development

Stefano Buono

Chairman

Investment Managers

Stefano Buono

Founder

Air Freight/Couriers

Raffaele Petrone

Director/Board Member

Electrical Products

Raffaele Petrone

Stefano Buono

Andrea Ruben Osvaldo Levi

Director/Board Member

Chief Executive Officer

Director/Board Member

IMMATICS N.V. Biotechnology

Jordan Silverstein

Edward Sturchio

Investor Relations Contact

General Counsel

Investment Managers

Stefano Buono

Private Equity Investor

Investment Managers

Stefano Buono

Chairman

Statistiche

Distribuzione geografica

Stati Uniti 13
Australia 10
Italia 9
Regno Unito 6
Francia 6

Settori

Health Technology 19
Consumer Services 13
Finance 5
Commercial Services 4
Distribution Services 3

Posizioni

Director/Board Member 219
Corporate Officer/Principal 103
Independent Dir/Board Member 65
Chairman 64
Undergraduate Degree 32
-40% Offerta a tempo limitato: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.
APPROFITTANE ORA